Global Topical Pain Relief Market Report 2022: Rising Demand Among Athletes for Topical Analgesics Spurs Growth - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--Oct 6, 2022--

The "Topical Pain Relief Market Analysis by Formulation, by Type (Prescription Pain Reliefs, Over-The-Counter Pain Reliefs), by Distribution Channel, and by Region - Global Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.

The less adverse effects than those of traditional oral medications, rising demand among athletes for topical analgesics, increase in the number of elderly people, and the prevalence of arthritis are some of the primary market drivers. However, the unfavorable smells and adverse symptoms related to painkillers are expected to restrain the market growth.

Segmentation: Topical Pain Relief Market Analysis Report 2021-2029 Formulation (Revenue, USD Million)

• Spray
• Patch
• Gel
• Cream
• Others

Type (Revenue, USD Million)

• Prescription pain reliefs
• Over-the-counter (OTC) pain reliefs

Distribution Channel (Revenue, USD Million)

• Retail & grocery stores.
• Pharmacies & drug stores
• E-commerce

Therapeutic Class (Revenue, USD Million)

• Non-opioids
• Opioids

By Region (Revenue, USD Million)

• U.S
• Canada

• Germany
• France
• UK
• Spain
• Italy
• Rest of Europe

• China
• Japan
• India
• Australia
• South Korea
• Rest of APAC

• Brazil
• Mexico
• Argentina
• Rest of LATAM

• South Africa
• GCC
• Rest of MEA

Key Topics Covered:

1. Research Methodology

2. Introduction: Thyroid Cancer Diagnosis

3. Executive Summary

4. Market Dynamics

5. Market Environment Analysis

6. COVID-19 Impact Analysis: Thyroid Cancer Diagnosis Market

7. Market Analysis by Technique

8. Market Analysis by Type

9. Market Analysis by End-use

10. Regional Market Analysis

11. North America Thyroid Cancer Diagnosis Market

12. Europe Thyroid Cancer Diagnosis Market

13. Asia Pacific Thyroid Cancer Diagnosis Market

14. Latin America Thyroid Cancer Diagnosis Market

15. MEA Thyroid Cancer Diagnosis Market

16. Competitor Analysis

17. Company Profiles

18. Conclusion

19. Recommendations

Companies Mentioned

• AdvaCare Pharma (India)
• Exzell Pharma (Canada)
• GlaxoSmithKline Plc (UK)
• Johnson & Johnson (US)
• Novartis AG (Switzerland)
• Pfizer Inc (US)
• Reckitt Benckiser Group plc (UK)
• Sanofi (France)
• Sun Pharmaceutical Industries Ltd (India)
• Topical BioMedics (US),

For more information about this report visit https://www.researchandmarkets.com/r/hdhjlx

View source version on businesswire.com:https://www.businesswire.com/news/home/20221006005468/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: HEALTH GENERAL HEALTH

SOURCE: Research and Markets

Copyright Business Wire 2022.